1 The effects of a single oral dose of the dopaminergic agonists lisuride (0.1 mg), terguride (0.25 mg) and bromocriptine (1.25 mg) on IOP were studied in eight normal volunteers using the non-contact tonometer. 2 Considering all post-dose measurements, compared with placebo, bromocriptine and lisuride but not terguride reduced IOP significantly in both eyes. 3 There was no significant difference between the ocular hypotensive effect of bromocriptine and lisuride. 4 Terguride reduced IOP significantly in the left eye at the 3 h time point after drug administration. 5 The result of this study confirms the reported ocular hypotensive effect of bromocriptine and showed that lisuride is as effective as bromocriptine in reducing IOP. 6 To evaluate the clinical importance of these drugs as ocular hypotensive agents other studies are needed using eye drops.